human normal immunoglobulin 10 % - bb 100 g/l solution for injection
БУЛ БИО - НЦЗПБ ЕООД - Имуноглобулин нормален човек за внесосудистого адм. - 100 g/l solution for injection
paroxetin sandoz 20 mg film - coated tablets
sandoz d.d. - Пароксетин - 20 mg film - coated tablets
paroxetin hexal 20 mg film - coated tablets
hexal ag - Пароксетин - 20 mg film - coated tablets
hyperrho s/d full dose 1500 iu solution for injection
Химимпорт Фарма АД - Анти-d (rh) имуноглобулин - solution for injection
chf - bulin 120 g/l solution for injection
БУЛ БИО - НЦЗПБ ЕООД - Имуноглобулин Човек Анти-Кримеан Хеморагична Треска - 120 g/l solution for injection
gammanorm 165 mg/ml solution for injection
octapharma (ip) limited - Имуноглобулин нормален човек за администриране на внесосудистого - 165 mg/ml solution for injection
rhesonativ 625 iu/ml solution for injection
octapharma (ip) ltd - Анти-d (rh) имуноглобулин - 625 iu/ml solution for injection
fortulin novolizer 6 micrograms/асtuation inhalation powder
meda pharma gmbh & co. kg - Формотерол - 6 micrograms/асtuation inhalation powder
fortulin novolizer 12 micrograms/actuation inhalation powder
meda pharma gmbh & co. kg - Формотерол - 12 micrograms/actuation inhalation powder
flebogamma dif (previously flebogammadif)
instituto grifols s.a. - Имуноглобулин нормален човек - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Имунни серуми и имуноглобулини - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.